Literature DB >> 7506372

Elevated frequencies of hprt mutant lymphocytes in cigarette-smoking mothers and their newborns.

M M Ammenheuser1, A B Berenson, N J Stiglich, E B Whorton, J B Ward.   

Abstract

Maternal cigarette smoking during pregnancy has been associated with increased perinatal mortality and low birth weight. Several epidemiological studies have demonstrated an association between smoking during pregnancy and an elevated risk of hematopoietic cancer in the child, but other studies have failed to confirm this association. We have used an assay for somatic cell mutation to evaluate the in utero effects of exposure to maternal cigarette smoking. Cord blood samples were obtained from 10 newborns whose mothers smoked cigarettes during pregnancy and 10 newborns of non-smoking mothers. Blood samples were also obtained from 5 of the smoking and 5 of the non-smoking mothers. Smoking status was confirmed in all samples by testing the blood plasma for cotinine. The frequency of lymphocytes containing mutations at the hypoxanthine phosphoribosyltransferase (hprt) locus was determined with an autoradiographic assay using cells that had been cryopreserved. The mothers who were smokers had a mean frequency (+/- SE) of 3.08 (+/- 0.55) variant (mutant) cells per 10(6) evaluatable lymphocytes. The frequency (Vf) in non-smokers was 1.07 (+/- 0.17) x 10(-6). The Vf of newborns of smokers was 2.17 (+/- 0.24) x 10(-6), and newborns of non-smokers had a Vf of 0.77 (+/- 0.13) x 10(-6). In both mothers and newborns the difference in Vf between smokers and non-smokers was statistically significant (p < 0.05). Maternal and newborn Vfs were significantly correlated (r = 0.88; p < 0.004), and there was a positive association (r = 0.86; p < 0.001) between the reported number of cigarettes smoked per day and the Vfs. This study provides further evidence that maternal smoking may be hazardous to the future health of children exposed in utero to mutagenic agents in cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506372     DOI: 10.1016/0027-5107(94)90221-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Future research directions to characterize environmental mutagens in highly polluted area.

Authors:  R J Srám
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

Review 2.  Identification of needs in biomarker research.

Authors:  J B Ward; R E Henderson
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

3.  Evaluation of frequencies of HPRT mutant lymphocytes in butadiene polymer workers in a Southeast Texas facility.

Authors:  Jeffrey K Wickliffe; Marinel M Ammenheuser; P Jene Adler; Sherif Z Abdel-Rahman; Jonathan B Ward
Journal:  Environ Mol Mutagen       Date:  2009-03       Impact factor: 3.216

4.  Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker.

Authors:  M M Ammenheuser; W E Bechtold; S Z Abdel-Rahman; J I Rosenblatt; D A Hastings-Smith; J B Ward
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

5.  Qualitatively and quantitatively similar effects of active and passive maternal tobacco smoke exposure on in utero mutagenesis at the HPRT locus.

Authors:  Stephen G Grant
Journal:  BMC Pediatr       Date:  2005-06-29       Impact factor: 2.125

6.  Effects of tobacco smoking during pregnancy on oxidative stress in the umbilical cord and mononuclear blood cells of neonates.

Authors:  Ednildes de Almeida Olympio Rua; Marcella Leite Porto; Jean Pierre Louzada Ramos; Breno Valentim Nogueira; Silvana S Meyrelles; Elisardo Corral Vasquez; Thiago C Pereira
Journal:  J Biomed Sci       Date:  2014-12-30       Impact factor: 8.410

7.  hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant.

Authors:  J B Ward; M M Ammenheuser; W E Bechtold; E B Whorton; M S Legator
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.